93 related articles for article (PubMed ID: 22096931)
1. [New antivirals against hepatitis C virus(protease inhibitors, polymerase inhibitors, and host factor targeting antivirals)].
Kato N; Muroyama R
Nihon Rinsho; 2011 May; 69 Suppl 4():275-81. PubMed ID: 22096931
[No Abstract] [Full Text] [Related]
2. Future directions in therapy for chronic hepatitis C.
Jensen DM; Ascione A
Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161
[TBL] [Abstract][Full Text] [Related]
3. [New times for the treatment of chronic hepatitis C].
Gerstoft J; Fomsgaard A
Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
[No Abstract] [Full Text] [Related]
4. Small molecule and novel treatments for chronic hepatitis C virus infection.
Harrison SA
Am J Gastroenterol; 2007 Oct; 102(10):2332-8. PubMed ID: 17617208
[TBL] [Abstract][Full Text] [Related]
5. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
Manns M
MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
[No Abstract] [Full Text] [Related]
6. [Hepatitis C therapy: a problem almost solved].
Rizzetto M
Recenti Prog Med; 2014 Jun; 105(6):225-6. PubMed ID: 25002283
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibitors of hepatitis C virus replication.
Neyts J
Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
[TBL] [Abstract][Full Text] [Related]
8. Directly acting antivirals against hepatitis C virus.
Soriano V; Vispo E; Poveda E; Labarga P; Martin-Carbonero L; Fernandez-Montero JV; Barreiro P
J Antimicrob Chemother; 2011 Aug; 66(8):1673-86. PubMed ID: 21652618
[TBL] [Abstract][Full Text] [Related]
9. New drugs for hepatitis C virus.
Pockros PJ
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):145-54. PubMed ID: 19072442
[TBL] [Abstract][Full Text] [Related]
10. Phase 3 study results released for telaprevir and HCV.
AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535
[No Abstract] [Full Text] [Related]
11. Prompt arrival of antivirals against hepatitis C for HIV patients.
Barreiro P; Vispo E
AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
[No Abstract] [Full Text] [Related]
12. Future treatment of chronic hepatitis C.
Keeffe EB
Antivir Ther; 2007; 12(7):1015-25. PubMed ID: 18018759
[TBL] [Abstract][Full Text] [Related]
13. Infectious diseases. First specific drugs raise hopes for hepatitis C.
Enserink M
Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
[No Abstract] [Full Text] [Related]
14. Protease inhibitors in hepatitis C: from chronic disease to cure.
Iqbal M; McCormick PA
Ir Med J; 2011 Sep; 104(8):230-1. PubMed ID: 22125874
[No Abstract] [Full Text] [Related]
15. Treating hepatitis C in lower-income countries.
Jayasekera CR; Barry M; Roberts LR; Nguyen MH
N Engl J Med; 2014 May; 370(20):1869-71. PubMed ID: 24720680
[No Abstract] [Full Text] [Related]
16. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C.
Moucari R; Forestier N; Larrey D; Guyader D; Couzigou P; Benhamou Y; Voitot H; Vidaud M; Seiwert S; Bradford B; Zeuzem S; Marcellin P
Gut; 2010 Dec; 59(12):1694-8. PubMed ID: 20861007
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of chronic hepatitis C: protease inhibitors significantly increase rate of healing].
Stiefelhagen P; Einecke D
MMW Fortschr Med; 2011 Jul; 153(29-31):14-5. PubMed ID: 21834169
[No Abstract] [Full Text] [Related]
18. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
Evans KA; Chai D; Graybill TL; Burton G; Sarisky RT; Lin-Goerke J; Johnston VK; Rivero RA
Bioorg Med Chem Lett; 2006 Apr; 16(8):2205-8. PubMed ID: 16455253
[TBL] [Abstract][Full Text] [Related]
19. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.
Broering R; Zhang X; Kottilil S; Trippler M; Jiang M; Lu M; Gerken G; Schlaak JF
Gut; 2010 Aug; 59(8):1111-9. PubMed ID: 20639253
[TBL] [Abstract][Full Text] [Related]
20. The Journey to the Discovery of Boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C.
Chen KX; Njoroge FG
Prog Med Chem; 2010; 49():1-36. PubMed ID: 20855037
[No Abstract] [Full Text] [Related]
[Next] [New Search]
